1Papadimitropoulos E,Wells G,Shea B,et al.Meta-analyses of efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women.Endocr Rev,2002,23:560 ～ 569.
2Koval PP,Seaton TL.Parathyroid hormone.Clinical Reviews in Bone & Mineral Metabolism,2005,3(1):31 ～ 38.
3Edwards CJ,Hart DJ,Spector TD.Oral stains and increased bone mineral density in postmenopausal women.Lancet,2000,355:2218 ～ 2219.
4Meunier PJ,Roux C,Seeman E,et al.The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal ostenporosis.The New England Journal of Medicine,2004,350(5):459 ～ 468.
5Wu XP,Liao EY,Huang G,et al.A comparison study of the reference curves of bone mineral density at different skeletal sites in native Chinese,Japanese,and American Caucasian women.Calcif Tissue Int,2003,73:122 ～ 132.
6Koh LK,Sedrine WB,Torralba TP,et al.A simple tool to identify asian women at increased risk of osteoporosis.Osteoporos Int.,2001,12 (8):699 ～ 705.
7Prevention and Management of Osteoporosis.WHO technical report series,No921,2003,53 ～ 63.
8Meunier PJ,Delmas PD,Eastell R,et al.Diagnosis and management of osteoporosis in postmenopausal women:clinical guidelines.International Committee for Osteoporosis Clinical Guidelines.Clin Ther.,1999,21 (6):1025 ～ 1044.
9Cauley JA,Robbins J,Chen Z,et al.Effects of estrogen plus progestin on risk of fracture and bone mineral density:the women's health initiative rsndomized trial.JAMA,2003,290(13):1729 ～ 1738.
10Morgante G,Farina M,Cianci A,et al.Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women.Gynecol Endocrinol,2004,18(4):194 ～ 198.
